Literature DB >> 2152837

Human cytomegalovirus induces expression of cellular topoisomerase II.

J D Benson1, E S Huang.   

Abstract

Previous work from our laboratory has suggested that topoisomerase II is required for replication of human cytomegalovirus (HCMV). In assays of confluent human embryonic lung cells infected with HCMV, topoisomerase II inhibitors exhibited an irreversible inhibition of viral DNA replication. However, Northern (RNA blot) and Western (immunoblot) analyses of confluent uninfected human embryonic lung cells detected very low levels of cellular topoisomerase II RNA and protein. Quantitation of human topoisomerase II RNA and protein levels at various times after HCMV infection revealed that HCMV induces increased intracellular levels of both topoisomerase II RNA and protein. Such accumulation began at early times of infection, continued through late in infection, and was not reduced by inhibition of viral DNA synthesis. This is the first report of such induction by a viral infection. Topoisomerase II was also detected in isolated HCMV virions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2152837      PMCID: PMC249031     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Human cytomegalovirus induces DNA-dependent RNA polymerases in human diploid cells.

Authors:  S Tanaka; S Ihara; Y Watanabe
Journal:  Virology       Date:  1978-08       Impact factor: 3.616

2.  Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus.

Authors:  M G Davis; S C Kenney; J Kamine; J S Pagano; E S Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

Review 3.  DNA topoisomerase poisons as antitumor drugs.

Authors:  L F Liu
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

4.  A cis-acting element within the 5' leader of a cytomegalovirus beta transcript determines kinetic class.

Authors:  A P Geballe; R R Spaete; E S Mocarski
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

5.  Effects of VM26 (teniposide), a specific inhibitor of type II DNA topoisomerase, on SV40 DNA replication in vivo.

Authors:  A Richter; U Strausfeld; R Knippers
Journal:  Nucleic Acids Res       Date:  1987-04-24       Impact factor: 16.971

6.  Roles of DNA topoisomerases in simian virus 40 DNA replication in vitro.

Authors:  L Yang; M S Wold; J J Li; T J Kelly; L F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

7.  Protein kinase C phosphorylates topoisomerase II: topoisomerase activation and its possible role in phorbol ester-induced differentiation of HL-60 cells.

Authors:  N Sahyoun; M Wolf; J Besterman; T Hsieh; M Sander; H LeVine; K J Chang; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

8.  Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitro.

Authors:  E C Mar; Y C Cheng; E S Huang
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

9.  Isolation of type I and II DNA topoisomerase mutants from fission yeast: single and double mutants show different phenotypes in cell growth and chromatin organization.

Authors:  T Uemura; M Yanagida
Journal:  EMBO J       Date:  1984-08       Impact factor: 11.598

10.  A comparison of adriamycin and mAMSA in vitro: cell lethality and SCE studies.

Authors:  C West; I J Stratford; N Barrass; E Smith
Journal:  Br J Cancer       Date:  1981-12       Impact factor: 7.640

View more
  16 in total

1.  Interactions between human cytomegalovirus IE1-72 and cellular p107: functional domains and mechanisms of up-regulation of cyclin E/cdk2 kinase activity.

Authors:  Zhigang Zhang; Shu-Mei Huong; Xin Wang; David Y Huang; Eng-Shang Huang
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

Review 2.  Molecular biology of cytomegalovirus.

Authors:  V C Emery; P D Griffiths
Journal:  Int J Exp Pathol       Date:  1990-12       Impact factor: 1.925

3.  Topoisomerase II cleavage of herpes simplex virus type 1 DNA in vivo is replication dependent.

Authors:  S N Ebert; S S Shtrom; M T Muller
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

4.  The human cytomegalovirus immediate early 2 protein dissociates cellular DNA synthesis from cyclin-dependent kinase activation.

Authors:  L Wiebusch; C Hagemeier
Journal:  EMBO J       Date:  2001-03-01       Impact factor: 11.598

5.  Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2.

Authors:  S K Srinivas; J W Sixbey
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

6.  Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling.

Authors:  R A Johnson; X Wang; X L Ma; S M Huong; E S Huang
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

7.  Murine cytomegalovirus stimulates cellular thymidylate synthase gene expression in quiescent cells and requires the enzyme for replication.

Authors:  G Gribaudo; L Riera; D Lembo; M De Andrea; M Gariglio; T L Rudge; L F Johnson; S Landolfo
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

8.  Identification and mapping of dimerization and DNA-binding domains in the C terminus of the IE2 regulatory protein of human cytomegalovirus.

Authors:  C J Chiou; J Zong; I Waheed; G S Hayward
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

9.  Human cytomegalovirus immediate-early gene 2 protein interacts with itself and with several novel cellular proteins.

Authors:  B A Furnari; E Poma; T F Kowalik; S M Huong; E S Huang
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

10.  E2F mediates dihydrofolate reductase promoter activation and multiprotein complex formation in human cytomegalovirus infection.

Authors:  M Wade; T F Kowalik; M Mudryj; E S Huang; J C Azizkhan
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.